We think RNA-Seq is the future of transcriptomics. Do you?

Whatever your answer, this rapidly developing area has its hurdles; data management and analysis requirements, de novo transcript assembly and biological inference to name but a few
.
RNA-Seq Europe puts you in front of the pioneers developing and applying the tools.

You might be looking for a comprehensive introduction to the field. Or wanting to hear detailed case studies that you can replicate. Whatever your motivations, RNA-Seq Europe is the perfect platform for you to discover the most innovative applicationsthat you can put into operation months ahead of plan.

*Why should you attend this meeting? *

There’ll be more opportunities than anywhere else to network and collaborate with industry and academic genomics experts from all over Europe, such as EPFL, TRON and Boeheringer Ingelheim

Ralph Schlapbach, Professor, Managing Director, ETH Zurich

Bayer, Bristol-Myers Squibb and GSK will help you cure your big data headaches and discover the best bioinformatics tools around to apply to your RNA-Seq Projects

Henrik Seidel, Global Coordination, Bioinformatics, Bayer Healthcare

Pioneers from Novartis, Roche, University of Cambridge and ETH will walk you through the transition from microarray to RNA-Seq so you can smoothly integrate the data sets

Patrick Descombes, Head of Functional Genomics Core, Nestle Institute of Health Sciences

Nestle, Bayer and Science for Life Laboratory will show you what tools are out there and how you can actually apply them

Edward Oakeley, Senior Group Head, Next Generation, Sequencing, Novartis

This meeting will help you get to grips with new technologies. Make the transition from microarrays. Make sense of the data that you have. RNA-Seq Europe is the place to learn, network and develop the means to achieve your goals.